Henan Zhenshi Biotechnology
Latest round
- Series B
Last raised
- Aug 2021
Total raised
- $100M
Investors
- 5
About Henan Zhenshi Biotechnology
Established in 2012 and based in Pingdingshan, China, Henan Zhenshi Biotechnology operates as an innovative drug developer that focuses on anti-acquired immune deficiency syndrome (AIDS) drugs. The company provides the research and development, production and sales of innovative drug. The product of the company includes azivudine tablets. The company develops innovative drug about anti-virus, anti-tumor, cardiovascular and cerebrovascular and liver diseases. The company will start Hong Kong stock initial public offering (IPO).
Who invested in Henan Zhenshi Biotechnology
5 investors across 1 round
See all investors in Henan Zhenshi Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Aug 27, 2021
Amount
$100M
Investors
Questions about Henan Zhenshi Biotechnology
Who invested in Henan Zhenshi Biotechnology?
Henan Zhenshi Biotechnology has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Henan Zhenshi Biotechnology raised?
Henan Zhenshi Biotechnology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Henan Zhenshi Biotechnology last raise money?
Henan Zhenshi Biotechnology's most recent round on record is a Series B, in Aug 2021.
What does Henan Zhenshi Biotechnology do?
Established in 2012 and based in Pingdingshan, China, Henan Zhenshi Biotechnology operates as an innovative drug developer that focuses on anti-acquired immune deficiency syndrome (AIDS) drugs.
Where is Henan Zhenshi Biotechnology headquartered?
Henan Zhenshi Biotechnology is headquartered in Pingdingshan, China.
Which VCs invest in companies like Henan Zhenshi Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Henan Zhenshi Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Henan Zhenshi Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.